AbCellera Biologics (ABCL) Debt to Equity (2018 - 2026)

AbCellera Biologics (ABCL) debt to equity from Dec 31, 2018 to Mar 31, 2026. The current AbCellera Biologics (ABCL) debt to equity is 0.00%. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.